SP Upgrades Lockheed Martin Outlook Amid Sustained Defense Demand Eli Lilly Targets Infectious Disease with Nearly 4 Billion Vaccine Deals White Case Advises Langer Laumann on Acquisition of Majority Stakes in CPM and NDC Huawei Advances Chip Design Method Amid US Restrictions Plans New Smartphone Chips This Fall London Stock Exchange Group Reports Income Growth Fueled by Tradeweb Performance Senegals Government ShakeUp Adds Uncertainty Amid Debt Crisis Aktis Oncology AKTS Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline AMGN Q1 2026 Earnings EPS Surpasses Estimates by 614 Stock Edges Higher Power REIT PW Q2 2025 Earnings Reports Positive EPS Amid Limited Disclosure GIL Q1 2026 Earnings EPS Beats Estimates by 73 amid Operational Strength KOF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status PROCEPT BioRobotics PRCT Rises on Positive Momentum Testing Key Resistance at 2847 DBA Centerspace CSR Slips 05 as Stock Tests Key Support Levels PAVmed Inc PAVM Gains 244 as Stock Tests Key Resistance Near 662 The ONE Group Hospitality STKS Holds Steady Near Key Support as Trading Volume Remains Subdued Kodiak AI Inc KDK Slips 193 as Stock Tests Key Support Levels Fox Corporation Stock Wall Street Analysts Target Price Insights Rocky Brands Q1 2026 Earnings EPS Miss Sends Stock Lower AXIA Energia Slips 3 as Shares Test Key Support Zone APA Corporation APA Q1 2026 Earnings EPS Surges Past Estimates But Stock Declines Amidst Mixed Signals Teledyne Technologies TDY Q1 2026 Earnings EPS Beats Estimates Stock Gains Amid Disciplined Execution ZION Q1 2026 Earnings EPS Surpasses Estimates by Over 7 Amid Solid Operating Performance KR Q1 2026 Earnings EPS Beats Estimates Stock Declines 4 Despite Strong Core Performance BHFAO Q1 2026 Earnings Preferred Shares Miss EPS Estimates Amid Narrow Surprise GAP Q1 2026 Earnings EPS Misses Estimates as Narrow Beat Fails to Materialize TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment